Mitesco (MITI) Amortization of Deferred Charges (2011 - 2026)

Mitesco (MITI) reported Amortization of Deferred Charges of $9127.0 for Q1 2026, down 98.39% quarter-over-quarter from $565431.0 in Q1 2022.

Mitesco (MITI) Amortization of Deferred Charges (2011 - 2026) Analysis & Trends

Mitesco (MITI) has 5 years of Amortization of Deferred Charges data on file, last reported at $9127.0 in Q1 2026.

Amortization of Deferred Charges for Q1 2026 came in at $9127.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $9127.0 (changed N/A YoY), and the FY2022 annual result was $565431.0, changed N/A from the prior year.
Amortization of Deferred Charges retreated to $9127.0 in Q1 2026 per MITI's latest filing, from $565431.0 in the prior quarter.
Over five years, Amortization of Deferred Charges peaked at $565431.0 in Q1 2022 and troughed at $9127.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn
10	Mitesco	-	-	-

Download Data